Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors

Journal of Clinical Psychopharmacology

Volumn 17, Issue 1, 1997, Pages 11-14

  Sheline, Yvette I ^a   Bardgett, Mark E ^a   Csernansky, John G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; FLUOXETINE; FLUVOXAMINE; HOMOVANILLIC ACID; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; HUMAN; PRIORITY JOURNAL;

ADULT; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; FLUVOXAMINE; FOLLOW-UP STUDIES; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 0031035532     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199702000-00003     Document Type: Article

References (20)

1. Scheinin M. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Med Biol 1985;63:1-7.
2. Johnson MR, Lydiard RB, Morton WA, Laird LK, Steele TE, Kellner CH, Ballenger JC. Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. J Psychiatr Res 1993;27:161-72.
3. Martensson B, Nyberg S, Toresson G, Brodin E, Bertilsson L. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid. Acta Psychiatr Scand 1989; 79:586-96.
4. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
5. Raskin A. Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. J Nerv Ment Dis 1969;148:87-98.
6. Lipman RS, Covi L, Downing RW, Fisher S, Kahn RJ, McNair DM, Rickels K, Smith VK Pharmacotherapy of anxiety and depression: rationale and study design. Psychopharmacol Bull 1981; 17:91-4.
7. Siever L, Kraemer H, Sack R, Angwin P, Berger P, Zarcone V, Barchas J, Brodie K. Gradients of biogenic amine metabolites in cerebrospinal fluid. Dis Nerv Syst 1975;36:13-6.
8. Csernansky JG, Wrona CT, Bardgett ME, Early TS, Newcomer JW. Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology 1993;110:145-51.
9. Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984;69:201-19.
10. Janowski A, Okada F, Manier DH, Applegate CD, Sulser F. Role of serotonergic input in the regulation of the β-adrenergic receptor-coupled adenylate cyclase system. Science 1982;218: 900-1.
11. Stockmeier CA, Martino AM, Kellar KJ. A strong influence of serotonin axons on β-adrenergic receptors in rat brain. Science 1985; 230:323-5.
12. Jibson M, Faull KF, Csernansky JG. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system. Biol Psychiatry 1990; 28:595-602.
13. Bertilsson L, Tuck J, Siwers B. Biochemical effects of zimeldine in man. Eur J Clin Pharmacol 1980;18:483-7.
14. Ross SB, Hall H, Renyi AL, Westerlund D. Effects of zimelidine on serotonergic and noradrenergic neurons after repeated administration in the rate. Psychopharmacology 1981;72-219-225.
15. Mishra R, Janowsky A, Sulser F. Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: subsensitivity without reduction in β-adrenergic receptor binding. Neuropharmacology 1980;19:983-7.
16. Hyttel J, Overo KF, Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 1984;83:20-7.
17. Mishra R, Janowsky A, Sulser F. Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine. Eur J Pharmacol 1979; 60:379-82.
18. Bjerkenstedt L, Edman G, Flyckt L, Hagenfeldt L, Sedvall G, Wiesel FA. Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor - a dose-response study in depressed patients. Psychopharmacology 1985;87:253-9.
19. Meltzer HY, Lowy MT. The serotonin hypothesis of depression. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:513-26.
20. Bowden CL, Koslow SH, Hanin I, Maas JW, Davis JM, Robins E. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid. Clin Pharmacol Ther 1985;37:316-24.